Interview With Justina Kiernan, PA-C: Discussing New Frontiers in Multiple Myeloma Immunotherapy

Interview with Sara Scott, PharmD, BCOP: Outpatient Protocols and Patient Management of Bispecific Antibodies

Interview with Sara Scott, PharmD, BCOP: Highlights from the 2025 International Myeloma Society Annual Meeting

Welcome to the Multiple Myeloma Resource Center! Here you’ll find current information, news items, highlights from the literature, and other resources that focus on multiple myeloma and the advanced practitioner’s role in delivering high-quality care to our patients. We’re excited to provide this information to you and your colleagues and hope this site is helpful to your practice. If you have any feedback or questions, please contact jadpro-editor@conexiant.com.


Charise Gleason, MSN, NP-C, AOCNP Winship Cancer Institute of Emory University Nell Hodgson Woodruff School of Nursing at Emory Healthcare	Amy Pierre, MSN, RN, ANP-BC Memorial Sloan Kettering Cancer Center Myeloma/Lymphoma Division Flatiron Health Real World Evidence Research Oncology

Role of the Clinical Pharmacist in Multiple Myeloma Management

Make it Happen: To Better Serve the Multiple Myeloma Community

Best Practices in Expanding Access to Bispecific Antibodies and Adverse Event Management

Disparities in Healthcare

International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma

Clinical Lymphoma, Myeloma & Leukemia

MRD directed consolidation in multiple myeloma-Are we there yet?

American Journal of Therapeutics

Global clinical trial landscape of chimeric antigen receptor T-cell therapy for multiple myeloma: Current status and future trends

EClinicalMedicine

Temporal trends in progression risk in smoldering myeloma: A systematic review

Annals of Hematology

Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study

Blood Reviews

Redefining central nervous system multiple myeloma: From rare phenomenon to emerging entity

European Journal of Haematology

Prognostic impact of the Hevylite Assay in patients with IgG or IgA multiple myeloma treated within the GMMG-MM5 trial

Clinical and Experimental Medicine

Clinical outcomes and safety of CD47-targeted immunotherapies across hematologic malignancies: A systematic review of monoclonal antibodies and fusion proteins in combination strategies

Cell Communication and Signaling

CAR-NK cell therapy in multiple myeloma: From preclinical and clinical landscape to joining the force for treatment strategies optimization

BMC Pulmonary Medicine

Evaluating pre-transplant nutritional indices as predictors of pneumonia and mortality in multiple myeloma patients post-autologous stem cell transplantation

Leukemia & Lymphoma

Treatment response assessment using whole body diffusion weighted-magnetic resonance imaging in myeloma: A retrospective cohort study

Multiple Myeloma Resource Center